IP Library Granted Patent US 7,025,932
Granted Patent B2
US 7,025,932 · App. 10/221,457 · Granted Apr 11, 2006

Control of gaseous sterilization

Assignee: Bioquell UK Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,025,932
App. No.
10/221,457
Granted
Apr 11, 2006
Kind
B2
Abstract

A method of sterilizing a sealable enclosure includes initially adjusting the relative humidity in the enclosure to a level substantially below ambient, circulating a carrier gas to the enclosure at a temperature raised above ambient and supplying a sterilant vapor or vapors to the circulating carrier gas sufficient to saturate substantially the gas. On cooling in the enclosure, a condensate of the sterilant vapor is formed on surfaces in the enclosure, which is measured whilst continuing to circulate the gas/vapor until a required amount of condensate has been formed on a the surface. Supply of sterilant vapor to the gas is terminated whilst circulating the saturated gas/vapor continues to maintain the condensate on the enclosure surfaces for a predetermined period of time. Finally the sterilant vapor is extracted from the chamber.

Claims (26)

1. A method of sterilizing a sealable enclosure comprising:

initially adjusting the relative humidity in the enclosure to a required level,

circulating a carrier gas to the enclosure at a temperature raised above ambient,

supplying a sterilant vapor or vapors to the circulating carrier gas,

distributing the gas/vapor throughout the enclosure,

continuing to circulate the gas/vapor through the enclosure until sterilization has been completed,

terminating the supply of sterilant vapor to the gas while continuing to circulate the saturated gas/vapor to maintain the condensate on the enclosure surfaces for a predetermined period of time, and

extracting the sterilant vapor from the chamber; sufficient sterilant vapor or vapors being added to the carrier gas to saturate substantially the gas whereby, on cooling in the enclosure, a condensate of the sterilant vapor is formed throughout the enclosure, measuring the amount of condensate formed on the surfaces of the enclosure and continuing to circulate the gas/vapor until a required amount of condensate has been formed on the enclosure surfaces.

2. A method as claimed in claim 1 , wherein the relative humidity of the enclosure is adjusted to about thirty to forty percent.

3. A method as claimed in claim 1 , wherein the sterilant vapor or vapors comprise hydrogen peroxide vapor and water vapor.

4. A method as claimed in claim 1 , wherein after said predetermined period of time for circulating the saturated gas/vapor, the gas/vapor is circulated over a catalyst to cause breakdown of the sterilant vapor into its constituent parts and water vapor is removed from the circulating gas, the dry gas being circulated through the enclosure until all of the sterilant has been extracted from the enclosure.

5. A method as claimed in claim 2 , wherein the sterilant vapor or vapors comprise hydrogen peroxide vapor and water vapor.

6. A method as claimed in claim 3 , wherein after said predetermined period of time for circulating the saturated gas/vapor, the gas/vapor is circulated over a catalyst to cause breakdown of the sterilant vapor into its constituent parts and water vapor is removed from the circulating gas, the dry gas being circulated through the enclosure until all of the sterilant has been extracted from the enclosure.

7. A method of sterilizing a sealable enclosure comprising:

adjusting the relative humidity in the enclosure to a required level;

circulating a carrier gas to the enclosure at a temperature raised above ambient;

supplying one or more sterilant vapors to the circulating carrier gas sufficient to substantially saturate the gas;

allowing the enclosure to cool until a condensate of the sterilant vapor is formed on surfaces throughout the enclosure;

measuring the amount of condensate formed on the surfaces of the enclosure and continuing to circulate the gas/vapor through the enclosure until a required amount of condensate has been formed on the enclosure surfaces;

reducing or terminating the supply of stenlant vapor to the gas while continuing to circulate the saturated gas/vapor to maintain the condensate on the enclosure surfaces for a predetermined period of time; and

extracting the sterilant vapor from the chamber.

8. A method as claimed in claim 7 , wherein the relative humidity of the enclosure is adjusted to about thirty to forty percent.

9. A method as claimed in claim 7 , wherein the one or more sterilant vapors comprise hydrogen peroxide vapor and water vapor.

10. A method as claimed in claim 7 , wherein after said predetermined period of time for circulating the saturated gas/vapor, the gas/vapor is circulated over a catalyst to cause breakdown of the one or more sterilant vapors into constituent parts and water vapor is removed from the circulating gas, the dry gas being circulated through the enclosure until all of the sterilant has been extracted from the enclosure.

11. A method as claimed in claim 8 , wherein the one or more sterilant vapors comprise hydrogen peroxide vapor and water vapor.

12. A method as claimed in claim 9 , wherein after said predetermined period of time for circulating the saturated gas/vapor, the gas/vapor is circulated over a catalyst to cause breakdown of the one or more sterilant vapors into constituent parts and water vapor is removed from the circulating gas, the dry gas being circulated through the enclosure until all of the stenlant has been extracted from the enclosure.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 21, 2010
From: UNIVERSITY OF WISCONSIN MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024719/0779 →
CHANGE OF ADDRESS Recorded Feb 24, 2010
From: BIOQUELL UK LIMITED
To: BIOQUELL UK LIMITED
Reel/Frame 023973/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2002
From: MARTIN, ANTHONY; WATLING, DAVID
To: BIOQUELL UK LIMITED
Reel/Frame 013489/0468 →
Priority Claims (1)
GB 0006824 · Mar 21, 2000 · national
Continuity (1)
Related Publication 20030031589A1 · Feb 13, 2003